StreetAlpha
OnKure Therapeutics, Inc. · SEC Form 4

OKUR Insider Trading

From SEC Form 417 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of OnKure Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $6K sold.

← OKUR stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$6K8 sales · 2 insiders
Net−$6Kbought minus sold
Planned sales–of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: sold $1KDecJanFeb2026-03: sold $2KMarAprMay2026-06: sold $2KJunJulAug2026-09: sold $1KSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when OKUR insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an OKUR officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every OKUR insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Sep 21, 2026Nicholas A SaccomanoPresident and CEOSale87$2.97$25911,160Sep 23Form 4
Sep 21, 2026Jason A. LeveroneCFOSale302$2.97$89818,500Sep 23Form 4
Jun 22, 2026Nicholas A SaccomanoPresident and CEOSale86$4.40$37811,247Jun 24Form 4
Jun 22, 2026Jason A. LeveroneCFOSale303$4.40$1K18,802Jun 24Form 4
Mar 23, 2026Nicholas A SaccomanoPresident and CEOSale86$4.16$3587,333Mar 24Form 4
Mar 23, 2026Jason A. LeveroneCFOSale301$4.16$1K16,000Mar 24Form 4
Dec 22, 2025Nicholas A SaccomanoPresident and CEOSale87$2.97$2587,419Dec 23Form 4
Dec 22, 2025Jason A. LeveroneCFOSale302$2.97$89716,301Dec 23Form 4
Sep 22, 2025Nicholas A SaccomanoPresident and CEOSale88$2.62$2313,506Sep 24Form 4
Sep 22, 2025Jason A. LeveroneCFOSale303$2.62$79412,603Sep 24Form 4
Jun 23, 2025Jason A. LeveroneCFOSale303$2.38$72112,906Jun 25Form 4
Jun 23, 2025Nicholas A SaccomanoPresident and CEOSale88$2.38$2093,594Jun 25Form 4
May 15, 2025Acorn Capital Advisors Gp, LLC10% ownerBuy1,400,000$1.85$2.6M1,129,730May 19Form 4
May 15, 2025Cormorant Private Healthcare Fund III LPInsiderSale1,813,439$1.85$3.4M0May 19Form 4
May 12, 2025Cormorant Global Healthcare Master Fund, LP10% ownerSale24,300$1.99$48K1,813,439May 14Form 4
🔒 2 more trades. Create a free account or sign in to see them all.

OKUR insider trading FAQ

Are OKUR insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of OKUR on the open market in 0 trades, and 2 sold $6K in 8 trades.

When did an OKUR insider last buy shares?

Acorn Capital Advisors Gp, LLC (10% owner) bought 1,400,000 shares for $2.6M on May 15, 2025, reported on May 19, 2025.

When did an OKUR insider last sell shares?

Nicholas A Saccomano (President and CEO) sold 87 shares for $259 on Sep 21, 2026.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice